HENLIUS Receives Filing Notice from China Securities Regulatory Commission for H-Share Full Circulation

Deep News01-18

HENLIUS (Stock Code: 02696) has announced that the company recently received the "Filing Notice for the 'Full Circulation' of Domestic Non-listed Shares of Shanghai Henlius Biotech, Inc." issued by the China Securities Regulatory Commission (CSRC). According to the filing notice, the company's filing with the CSRC for the implementation of an H-share full circulation of a total of 183 million non-listed shares held by certain shareholders has been completed. If the company does not complete the conversion and listing for this H-share full circulation within 12 months from the date of the filing notice and intends to continue the process, it must update the filing materials with the CSRC.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment